Thus YAP expression and activation may be a reason for AXL induction in drug-resistant adenocarcinomas and some other cancer types; though we did not evaluate AXL expression following YAP knockdown, which would have been interesting. The gene discussed is AXL; the disease is adenocarcinoma.